Crestline Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-101,035
| Closed | -$8.27M | – | 468 |
|
|
2024
Q4 | $8.27M | Buy |
101,035
+47,452
| +89% | +$3.88M | 0.28% | 69 |
|
|
2024
Q3 | $6.12M | Buy |
+53,583
| New | +$6.12M | 0.32% | 86 |
|
|
2020
Q3 | – | Sell |
-7,000
| Closed | -$221K | – | 135 |
|
|
2020
Q2 | $221K | Buy |
+7,000
| New | +$221K | 0.04% | 57 |
|